Schwenksville, PA, United States of America

Stephen B Ruddy

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 4.1

ph-index = 19

Forward Citations = 1,522(Granted Patents)


Location History:

  • Schwenkville, PA (US) (1997)
  • Schwenksville, PA (US) (1994 - 2014)

Company Filing History:


Years Active: 1994-2014

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: Stephen B Ruddy: Innovator in Pharmaceutical Compositions

Introduction

Stephen B Ruddy, hailing from Schwenksville, PA, is a prominent inventor with an impressive portfolio of 31 patents. His innovative contributions primarily focus on pharmaceutical compositions, particularly those aimed at enhancing safety and effectiveness in drug delivery.

Latest Patents

Among Ruddy's notable patents is the development of abuse-resistant pharmaceutical compositions. This invention features a controlled-release formulation that includes a unique coating for discrete active particles. The design ensures that the abuse-capable compounds are difficult to separate from their matrix, thus decreasing potential misuse. Furthermore, Ruddy has pioneered in vitro methods for assessing the efficacy of microparticulate or nanoparticulate active agents. These methods accurately represent human physiological conditions, facilitating better evaluations of drug formulations.

Career Highlights

Throughout his career, Ruddy has made significant strides in the pharmaceutical industry. He has collaborated with esteemed companies such as Elan Pharma International Limited and Sterling Winthrop Inc., where he utilized his expertise to advance drug formulation techniques.

Collaborations

Stephen has worked alongside respected professionals including Mary E Roberts and Eugene Rex Cooper. These collaborations have fostered a dynamic exchange of ideas, resulting in innovative solutions in the realm of pharmaceuticals.

Conclusion

Stephen B Ruddy remains a vital figure in the pharmaceutical sector, with his extensive patent portfolio underscoring his commitment to innovation. His work, especially in the field of abuse-resistant formulations, exemplifies the ongoing efforts to enhance drug safety and efficacy, making a substantial impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…